| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 01/22/2013 | CA2602610C Benzimidazole compound |
| 01/22/2013 | CA2338524C Inhibitors of urokinase and blood vessel formation |
| 01/17/2013 | WO2013009543A1 Polycyclic pyrrolidine-2,5-dione derivatives as -formyl peptide receptor like-1 (fprl-1) receptor modulators |
| 01/17/2013 | WO2013009102A2 Cartilage cell treating agent comprising collagen, hyaluronic acid derivative, and stem cell derived from mammal umbilical cord |
| 01/17/2013 | WO2013008928A1 Macrolide derivative |
| 01/17/2013 | WO2013007807A1 Selected cimicifuga fractions for the treatment of osteoporosis |
| 01/17/2013 | WO2013007676A1 Aminomethyl quinolone compounds |
| 01/17/2013 | WO2012122165A3 Substituted n-aryl pyridinones |
| 01/17/2013 | US20130018089 Method of treating inflammatory arthropathies with suppressors of cpg oligonucleotides |
| 01/17/2013 | US20130018071 Solid Forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| 01/17/2013 | US20130018068 Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1 |
| 01/17/2013 | US20130018067 Polycyclic pyrrolidine-2,5-dione derivatives as -formyl peptide receptor like-1 (fprl-1) receptor modulators |
| 01/17/2013 | US20130018060 Inhibitors of bruton's tyrosine kinase |
| 01/17/2013 | US20130018052 2-pyridyl substituted imidazoles as alk5 and/or alk4 inhibitors |
| 01/17/2013 | US20130018051 Bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 01/17/2013 | US20130018048 Oxazole derivatives useful as modulators of faah |
| 01/17/2013 | US20130018039 Imidazolyl-imidazoles as kinase inhibitors |
| 01/17/2013 | US20130018036 Substituted indazole derivatives active as kinase inhibitors |
| 01/17/2013 | US20130018034 Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as jak inhibitors |
| 01/17/2013 | US20130018031 Aminoalkylpyrimidine derivatives as histamine h4 receptor antagonists |
| 01/17/2013 | US20130018019 Aromatic compounds having sphingosine-1-phosphonate (s1p) receptor activity |
| 01/17/2013 | US20130018017 Quinolinone derivatives as parp and tank inhibitors |
| 01/17/2013 | US20130018005 Glycoside derivatives and uses thereof |
| 01/17/2013 | US20130017998 Novel modified galectin 9 proteins and use thereof |
| 01/17/2013 | US20130017262 Immediate/delayed drug delivery |
| 01/17/2013 | US20130017255 Tamper Resistant Dosage Form Comprising an Adsorbent and an Adverse Agent |
| 01/17/2013 | US20130017234 Implant modified with non-hydroxylated vitamin d precursors |
| 01/17/2013 | US20130017233 Tricalcium Phosphate Coarse Particle Compositions and Methods for Making the Same |
| 01/17/2013 | US20130017232 Synthetic bone grafts |
| 01/17/2013 | US20130017228 Methods and compositions for bone formation |
| 01/17/2013 | US20130017226 TNF-A and TWEAK Dual Antagonist for the Prophylaxis and Treatment of Autoimmune Diseases |
| 01/17/2013 | US20130017212 THERAPEUTIC USE OF THE ß2m PROTEIN |
| 01/17/2013 | US20130017208 Anti-IL-6 Antibodies, Compositions, Methods and Uses |
| 01/17/2013 | US20130017203 Methods of treating and preventing staphylococcus aureus infections and associated conditions |
| 01/17/2013 | US20130017193 Antibody formulations |
| 01/17/2013 | US20130017188 Modulation of sgk1 expression in th17 cells to modulate th17-mediated immune responses |
| 01/17/2013 | US20130017169 Multimeric forms of therapeutic proteins and uses thereof |
| 01/17/2013 | US20130017149 Pharmaceutical compounds |
| 01/17/2013 | CA2841983A1 Polycyclic pyrrolidine-2,5-dione derivatives as -formyl peptide receptor like-1 (fprl-1) receptor modulators |
| 01/17/2013 | CA2839395A1 Aminomethyl quinolone compounds |
| 01/16/2013 | EP2545932A1 Selected cimicifuga fractions for treating osteoporosis |
| 01/16/2013 | EP2545052A1 Imidazopyridines syk inhibitors |
| 01/16/2013 | EP2544684A1 4,4-disubstituted piperidine derivatives useful as inhibitors of dipeptidyl peptidase-1 (dpp-1) |
| 01/16/2013 | EP2544662A2 Foamable formulation |
| 01/16/2013 | CN202666023U Osteopathy treatment combined type medicine patch |
| 01/16/2013 | CN102884047A 2-pyridone compounds |
| 01/16/2013 | CN102883717A Composition for treating bone disease comprising a glyceollin as an active ingredient |
| 01/16/2013 | CN102876627A Tenocyte cell culturing method |
| 01/16/2013 | CN102876553A Preparation method of high-quality mung bean liquor |
| 01/16/2013 | CN102875615A Extraction method and application of falcate dolichos root or leaf glucoside A and total saponins of falcate dolichos root or leaf |
| 01/16/2013 | CN102875518A Genipin methyl ether, preparation method and medicine application thereof |
| 01/16/2013 | CN102875480A Quinazolinone vasoinhibitors, and preparation method and medical application thereof |
| 01/16/2013 | CN102875478A Amine salts of a crth2 antagonist |
| 01/16/2013 | CN102875466A Isoquinolinone derivatives, and preparation method and medical purpose thereof |
| 01/16/2013 | CN102872442A Traditional Chinese medicine capsule for treating scapulohumeral periarthritis |
| 01/16/2013 | CN102872426A Plaster for treating cervical spondylosis, lumbar vertebra disease and hyperosteogeny |
| 01/16/2013 | CN102872420A Medicine for treating rheumatic arthritis and preparation method thereof |
| 01/16/2013 | CN102872413A Chinese medicinal composition for treating cervical spondylosis |
| 01/16/2013 | CN102872387A Traditional Chinese medicine composition for treating arthralgia caused by wind-damp-heat pathogens |
| 01/16/2013 | CN102872340A External-use honeysuckle-dull leaf powder for treating temporomandibular disorders |
| 01/16/2013 | CN102872314A Drug for treating gout and preparation method for drug |
| 01/16/2013 | CN102872308A Snake gourd fruit tablets for promoting circulation of qi and removing stasis |
| 01/16/2013 | CN102872301A Anti-rheumatism medicinal liquor and using method thereof |
| 01/16/2013 | CN102872299A Medicine compound for treating osteoporosis and osteoporosis fracture |
| 01/16/2013 | CN102872293A Traditional Chinese medicinal powder for treating rheumatism and rheumatoid disease |
| 01/16/2013 | CN102872287A Traditional Chinese medicine composition for treating femoral head necrosis and preparation method thereof |
| 01/16/2013 | CN102872286A Traditional Chinese medicine composition for curing lumbar interveterbral disc protrusion and preparation method thereof |
| 01/16/2013 | CN102872285A Multi-functional medicine pillow |
| 01/16/2013 | CN102872284A Chinese medicinal composition for treating hyperosteogeny and preparation method thereof |
| 01/16/2013 | CN102872283A Traditional Chinese medicine composition for treating bone fracture |
| 01/16/2013 | CN102872282A Han Shi Bi Ting Wan for treating ankylosing spondylitis |
| 01/16/2013 | CN102872278A Vertebra and bone strengthening capsule for treating lumbar spondylosis |
| 01/16/2013 | CN102872254A Granules for activating blood and removing stasis |
| 01/16/2013 | CN102872252A Medicinal composition for treating rheumatic pain |
| 01/16/2013 | CN102872238A Medicine for treating osteoarthrosis and preparation method thereof |
| 01/16/2013 | CN102872232A Traditional Chinese medicine for treating lumbar disc herniation |
| 01/16/2013 | CN102872230A Chinese medicinal preparation for treating scapulohumeral periarthritis |
| 01/16/2013 | CN102872226A Traditional Chinese medicine composition for treating arthralgia |
| 01/16/2013 | CN102872215A Traditional Chinese medicine composition for promoting fracture healing |
| 01/16/2013 | CN102872182A Preparation method of drug for treating gout |
| 01/16/2013 | CN102872181A Preparation method of gout treating medicine oral liquid |
| 01/16/2013 | CN102872165A Production process for efficiently preparing high-content steopractic general flavone |
| 01/16/2013 | CN102872012A Compound capable of inhibiting protein kinase and application thereof |
| 01/16/2013 | CN102370907B Traditional Chinese medicine for treating scapulohumeral periarthritis |
| 01/16/2013 | CN102240391B Traditional Chinese medicine solution for health promotion |
| 01/16/2013 | CN102228556B Externally applied drug for fumigating treatment of arthritis |
| 01/16/2013 | CN102078516B Traditional Chinese medicine for treating bone injury |
| 01/16/2013 | CN101906128B Estrone compound, as well as preparation method and application thereof |
| 01/15/2013 | US8354448 Use of (−)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of type 2 diabetes |
| 01/15/2013 | US8354397 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 01/15/2013 | US8354376 Osteogenic devices and methods of use thereof for repair of endochondral bone, osteochondral and chondral defects |
| 01/15/2013 | CA2571742C Canine osteoarthritis diet formulation |
| 01/15/2013 | CA2563830C Transdermal steroid formulation |
| 01/15/2013 | CA2483817C Novel ligands that are inhibitors of the rar receptors, process for preparing them and use thereof in human medicine and in cosmetics |
| 01/10/2013 | WO2013006758A1 Diphosphate mimetics and uses thereof |
| 01/10/2013 | WO2013006372A1 Method of treating pathologic heterotopic ossification |
| 01/10/2013 | WO2013005839A1 Phosphorylated peptide, hard tissue and/or ectopic calcification inhibitor, antibody, and hard tissue and/or ectopic calcification promoter |
| 01/10/2013 | WO2013004984A1 Tricyclic compounds for use as kinase inhibitors |
| 01/10/2013 | WO2013004291A1 Cyclic amine derivatives as ep4 receptor agonists |
| 01/10/2013 | WO2013003899A1 Methods of treating or preventing rheumatic disease |